Literature DB >> 15045522

Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination.

M Van Goethem1, K Schelfout, E Kersschot, C Colpaert, I Verslegers, I Biltjes, W A Tjalma, J Weyler, A De Schepper.   

Abstract

The enhancing area surrounding breast carcinoma on MR mammography is correlated with findings from pathological examination. We studied 194 patients with breast cancer who underwent preoperative MR mammography. Of all malignant lesions presenting with an enhancing surrounding area on MR mammography, morphologic features including long spicules, a ductal pattern, diffuse enhancement or nodules were evaluated and compared with histopathological examination. A double breast coil was used; we performed a 3D FLASH sequence with contiguous coronal slices of 2 mm, before and after injection of 0.2 mmol/kg GD-DTPA, and subtraction images were obtained. In total, 297 malignant lesions were detected at MR mammography and 101 of them had one or more types of enhancing surrounding area. In 49 of the 53 cancers with long spicules and in 49 of the 55 cancers with surrounding ductal pattern of enhancement, pathological examination showed in situ and/or invasive carcinoma. Multiple nodules adjacent to the carcinoma were seen in 20 patients and corresponded with six cases of invasive and ten cases of ductal in situ carcinoma. A diffuse enhancing area next to a mass was seen in ten patients and consisted of carcinoma in all cases: seven in situ and three invasive carcinomas. Enhancing areas including long spicules, a ductal pattern, noduli, or diffuse enhancement surrounding a carcinoma corresponded with in situ or invasive extension of the carcinoma in 92.5, 89, 80 and 100% of cases, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15045522     DOI: 10.1007/s00330-004-2295-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  15 in total

1.  Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging.

Authors:  H Satake; K Shimamoto; A Sawaki; R Niimi; Y Ando; T Ishiguchi; T Ishigaki; K Yamakawa; T Nagasaka; H Funahashi
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

Review 2.  MR imaging of the breast for the detection, diagnosis, and staging of breast cancer.

Authors:  S G Orel; M D Schnall
Journal:  Radiology       Date:  2001-07       Impact factor: 11.105

3.  Staging of symptomatic primary breast cancer with MR imaging.

Authors:  H Mumtaz; M A Hall-Craggs; T Davidson; K Walmsley; W Thurell; M W Kissin; I Taylor
Journal:  AJR Am J Roentgenol       Date:  1997-08       Impact factor: 3.959

4.  Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography.

Authors:  P L Davis; M J Staiger; K B Harris; M A Ganott; J Klementaviciene; K S McCarty; H Tobon
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation.

Authors:  P C Stomper; J L Connolly; J E Meyer; J R Harris
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

6.  Classification of hypervascularized lesions in CE MR imaging of the breast.

Authors:  F Baum; U Fischer; R Vosshenrich; E Grabbe
Journal:  Eur Radiol       Date:  2002-02-02       Impact factor: 5.315

7.  Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions.

Authors:  C Walter; K Scheidhauer; A Scharl; U-J Goering; P Theissen; H Kugel; T Krahe; U Pietrzyk
Journal:  Eur Radiol       Date:  2003-01-23       Impact factor: 5.315

8.  Ductal carcinoma in situ: MR imaging-histopathologic correlation.

Authors:  R Gilles; B Zafrani; J M Guinebretière; M Meunier; O Lucidarme; A A Tardivon; F Rochard; D Vanel; S Neuenschwander; R Arriagada
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

9.  Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy.

Authors:  K Wasser; H P Sinn; C Fink; S K Klein; H Junkermann; H P Lüdemann; I Zuna; S Delorme
Journal:  Eur Radiol       Date:  2002-11-30       Impact factor: 5.315

10.  Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ.

Authors:  R Holland; J H Hendriks; A L Vebeek; M Mravunac; J H Schuurmans Stekhoven
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

View more
  10 in total

1.  Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients.

Authors:  Eline E Deurloo; William F A Klein Zeggelink; H Jelle Teertstra; Johannes L Peterse; Emiel J Th Rutgers; Sara H Muller; Harry Bartelink; Kenneth G A Gilhuijs
Journal:  Eur Radiol       Date:  2005-11-19       Impact factor: 5.315

2.  Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.

Authors:  Jia Wu; Bailiang Li; Xiaoli Sun; Guohong Cao; Daniel L Rubin; Sandy Napel; Debra M Ikeda; Allison W Kurian; Ruijiang Li
Journal:  Radiology       Date:  2017-07-14       Impact factor: 11.105

3.  Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI.

Authors:  N Morakkabati-Spitz; C Leutner; H Schild; F Traeber; C Kuhl
Journal:  Eur Radiol       Date:  2005-04-20       Impact factor: 5.315

4.  Lupus panniculitis involving the breast.

Authors:  Josep M Sabaté; Antonio Gómez; Sofía Torrubia; Teresa Salinas; Montse Clotet; Enrique Lerma
Journal:  Eur Radiol       Date:  2005-06-04       Impact factor: 5.315

5.  Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography.

Authors:  Keiko Oshida; Takeshi Nagashima; Takuya Ueda; Hiroshi Yagata; Naoto Tanabe; Shigeharu Nakano; Takashi Nikaidou; Hiroyuki Funatsu; Hideyuki Hashimoto; Masaru Miyazaki
Journal:  Eur Radiol       Date:  2005-03-24       Impact factor: 5.315

Review 6.  Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?

Authors:  Francesco Sardanelli; Franca Podo
Journal:  Eur Radiol       Date:  2006-09-29       Impact factor: 5.315

7.  Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer.

Authors:  Hao Xu; Jieke Liu; Zhe Chen; Chunhua Wang; Yuanyuan Liu; Min Wang; Peng Zhou; Hongbing Luo; Jing Ren
Journal:  Eur Radiol       Date:  2022-01-25       Impact factor: 5.315

8.  Application of an exogenous hyperoxic contrast agent in MR mammography: initial results.

Authors:  Dorothee R Fischer; Jürgen R Reichenbach; Alexander Rauscher; Jan Sedlacik; Werner A Kaiser
Journal:  Eur Radiol       Date:  2004-09-22       Impact factor: 5.315

9.  Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions-a feasibility study.

Authors:  Kristina Åhsberg; Anna Gardfjell; Emma Nimeus; Rogvi Rasmussen; Catharina Behmer; Sophia Zackrisson; Lisa Ryden
Journal:  World J Surg Oncol       Date:  2020-05-21       Impact factor: 2.754

10.  The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.

Authors:  Lisa Ryden; Sophia Zackrisson; Kristina Åhsberg; Anna Gardfjell; Emma Nimeus
Journal:  BMC Cancer       Date:  2021-10-18       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.